Exploitation
Patents
Filed National
PAT n. 120016 – “Biobased optical gel compositions for physically unclonable tags and production method thereof”, Inventors: Palma SICJ, Roque ACA, January 2025
P1558.0 PP – “Polypeptide binders, methods and uses thereof”, Inventors: Roque ACA, Dias AMGC, Pina AS, Brandão MJAA, Teixeira GCG; June 2024
PT065588 – “Protein for Detecting the Presence of Peptidoglycan, Muropeptides or Bacterial Cells, Sensor and Uses Thereof”, Inventors: P.L. Almeida, R.G. Sobral, M.L. Miragaia, A.C. Roque, M.I. Grilo, A.S. Pina; December 2019
PAT n. 108205 U “Material compósito com resposta a estímulos e respetivo processo de produção e aplicação como película sensitiva”, Inventors: Roque ACA, Hussain A, Gruber J, Semeano ATS, February 2015.
PAT n. 107379 “Extração líquido-líquido magnética para a purificação e separação de substâncias”, Inventors: Roque ACA, Dhadge VL, Azevedo AM, Aires-Barros MR, December 2014.
Filed International
PCT/IB2020/054794 “Peptide ionogels composition, methods and uses thereof” Inventors: A. C. A. Roque, C. A. M. Esteves, R. V. Ulijn (priority date 20/05/2019), WO2020234806 (publication date 28/11/2020), EP3973550 (Granted)
PCT/IB2016/050697 “A stimuli-responsive composite material, respective production process and application as a sensitive film” Inventors: Roque ACA, Hussain A, Gruber J, Semeano ATS, (priority date 10/02/20215); WO2016128907 (publication date 18/08/2016), EP3256545 (Granted), converted to BR112017017127A2 (Granted)
PCT n. 7844J/3197/2014000078, “Magnetic liquid-liquid extraction for purification and partitioning of substances”, Inventors: Roque ACA, Dhadge VL, Azevedo AM, Aires-Barros MR, December 2014.
PCT/GB 03/04524 and WO/2004/035199 “Affinity adsorbents for immunoglobulins”, Inventors: Roque ACA, Taipa MA, Lowe CR, October 2003.
EU-funded Innovations
PURE project
Functionalised Adsorbents for Bioseparation with increased productivity leading to cost and environmental reduction of separation processes applicable to monoclonal antibodies and other biologicals (link).
Affinity reagents targeting biological targets (i.e. monoclonal antibodies) for purification processes (link).